212 related articles for article (PubMed ID: 2903937)
1. Catecholamine metabolism in pheochromocytoma and normal adrenal medullae.
Nakada T; Furuta H; Katayama T
J Urol; 1988 Dec; 140(6):1348-51. PubMed ID: 2903937
[TBL] [Abstract][Full Text] [Related]
2. Expression of mRNA coding for four catecholamine-synthesizing enzymes in human adrenal pheochromocytomas.
Isobe K; Nakai T; Yukimasa N; Nanmoku T; Takekoshi K; Nomura F
Eur J Endocrinol; 1998 Apr; 138(4):383-7. PubMed ID: 9578504
[TBL] [Abstract][Full Text] [Related]
3. Dihydroxyphenylglycol in pheochromocytoma: its diagnostic use for norepinephrine dominant tumor.
Nakada T; Sasagawa I; Kubota Y; Suzuki H; Ishigooka M; Watanabe M
J Urol; 1996 Jan; 155(1):14-8. PubMed ID: 7490813
[TBL] [Abstract][Full Text] [Related]
4. Abnormal catecholamine metabolism in pheochromocytoma.
Rubio MC; Barontini MB
Medicina (B Aires); 1985; 45(6):631-6. PubMed ID: 2878347
[No Abstract] [Full Text] [Related]
5. Monoamine oxidase A down-regulation contributes to high metanephrine concentration in pheochromocytoma.
Grouzmann E; Matter M; Bilz S; Herren A; Triponez F; Henzen C; Kim KS; Zulewski H; Buclin T; Brakch N; Abid K
J Clin Endocrinol Metab; 2012 Aug; 97(8):2773-81. PubMed ID: 22569243
[TBL] [Abstract][Full Text] [Related]
6. PGE2: opposite effect on catecholamine release from phaeochromocytoma and adrenal medulla.
Gutman Y; Boonyaviroj P
Prostaglandins; 1976 Oct; 12(4):487-91. PubMed ID: 972999
[TBL] [Abstract][Full Text] [Related]
7. Pheochromocytoma: rediscovery as a catecholamine-metabolizing tumor.
Eisenhofer G; Goldstein DS; Kopin IJ; Crout JR
Endocr Pathol; 2003; 14(3):193-212. PubMed ID: 14586065
[TBL] [Abstract][Full Text] [Related]
8. Polyoma-induced neoplasms of the mouse adrenal medulla. Characterization of the tumors and establishment of cell lines.
Tischler AS; Freund R; Carroll J; Cahill AL; Perlman RL; Alroy J; Riseberg JC
Lab Invest; 1993 May; 68(5):541-9. PubMed ID: 8098784
[TBL] [Abstract][Full Text] [Related]
9. Unilateral adrenal catecholamine excess. Pheochromocytoma or possible sporadic medullary hyperplasia.
Bauman A
Arch Intern Med; 1982 Feb; 142(2):377-8. PubMed ID: 7059264
[TBL] [Abstract][Full Text] [Related]
10. Remarkably suppressed manganese superoxide dismutase activity in malignant pheochromocytoma.
Nakada T; Kubota Y; Sasagawa I; Yagisawa T; Watanabe M; Ishigooka M
J Urol; 1995 Jun; 153(6):1787-90. PubMed ID: 7752317
[TBL] [Abstract][Full Text] [Related]
11. Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes.
Eisenhofer G; Walther MM; Huynh TT; Li ST; Bornstein SR; Vortmeyer A; Mannelli M; Goldstein DS; Linehan WM; Lenders JW; Pacak K
J Clin Endocrinol Metab; 2001 May; 86(5):1999-2008. PubMed ID: 11344198
[TBL] [Abstract][Full Text] [Related]
12. Opposite effect of PGE2 on cAMP levels in human adrenal medulla and pheochromocytoma.
Boonyaviroj P; Gutman Y
Experientia; 1977 Aug; 33(8):1113-4. PubMed ID: 196898
[TBL] [Abstract][Full Text] [Related]
13. [Expression of mRNAs coding for catecholamine synthesizing enzymes in human adrenal pheochromocytoma].
Isobe K; Yukimasa N; Takekoshi K; Nomura F; Nakai T
Rinsho Byori; 1995 Jun; 43(6):540-4. PubMed ID: 7602797
[TBL] [Abstract][Full Text] [Related]
14. Morphology, Biochemistry, and Pathophysiology of MENX-Related Pheochromocytoma Recapitulate the Clinical Features.
Wiedemann T; Peitzsch M; Qin N; Neff F; Ehrhart-Bornstein M; Eisenhofer G; Pellegata NS
Endocrinology; 2016 Aug; 157(8):3157-66. PubMed ID: 27254000
[TBL] [Abstract][Full Text] [Related]
15. Enkephalin- and somatostatin-like immunoreactivities in human adrenal medulla and pheochromocytoma.
Lundberg JM; Hamberger B; Schultzberg M; Hökfelt T; Granberg PO; Efendić S; Terenius L; Goldstein M; Luft R
Proc Natl Acad Sci U S A; 1979 Aug; 76(8):4079-83. PubMed ID: 386355
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine hydroxylase in human adrenal and pheochromocytoma: localization, kinetics, and catecholamine inhibition.
Waymire JC; Weiner N; Schneider FH; Goldstein M; Freedman LS
J Clin Invest; 1972 Jul; 51(7):1798-804. PubMed ID: 4402349
[TBL] [Abstract][Full Text] [Related]
17. Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?
Grouzmann E; Tschopp O; Triponez F; Matter M; Bilz S; Brändle M; Drechser T; Sigrist S; Zulewski H; Henzen C; Fischli S; Abid K
PLoS One; 2015; 10(5):e0125426. PubMed ID: 25946206
[TBL] [Abstract][Full Text] [Related]
18. Nuclear DNA ploidy pattern and tissue levels of dihydroxyphenylalanine and catecholamines in pheochromocytoma.
Sasagawa I; Nakada T; Kubota Y; Ishigooka M; Sawamura T; Suzuki Y
Urol Int; 1995; 54(4):181-3. PubMed ID: 7610501
[TBL] [Abstract][Full Text] [Related]
19. Overnight excretion of urinary catecholamines and metabolites in the detection of pheochromocytoma.
Peaston RT; Lennard TW; Lai LC
J Clin Endocrinol Metab; 1996 Apr; 81(4):1378-84. PubMed ID: 8636337
[TBL] [Abstract][Full Text] [Related]
20. [Expression of urotensin II mRNA in normal adrenal medulla and pheochromocytoma tissues].
Liu GQ; Zeng ZP; Li HZ; Fan XR; Liu DM; Tong AL; Zheng X
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(14):1225-8. PubMed ID: 12930635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]